Future of reperfusion therapy for acute myocardial infarction

Lancet. 1999 Aug 28;354(9180):695-7. doi: 10.1016/S0140-6736(99)00263-9.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Adult
  • Angioplasty, Balloon, Coronary / trends*
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / adverse effects
  • Forecasting
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / therapy*
  • Myocardial Reperfusion / trends*
  • Stents / trends
  • Survival Rate
  • Tenecteplase
  • Thrombolytic Therapy / trends*
  • Tissue Plasminogen Activator / administration & dosage*
  • Tissue Plasminogen Activator / adverse effects

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator
  • Tenecteplase